PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury

The cyclic AMP-dependent protein kinase (PKA), which activates prosurvival signaling proteins, has been implicated in the expression of long-term potentiation and hippocampal long-term memory. It has come to light that H89 commonly known as the PKA inhibitor have diverse roles in the nervous system...

Full description

Saved in:
Bibliographic Details
Main Authors: Juhyun Song, So Yeong Cheon, Won Taek Lee, Kyung Ah Park, Jong Eun Lee
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2015/374520
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556451621502976
author Juhyun Song
So Yeong Cheon
Won Taek Lee
Kyung Ah Park
Jong Eun Lee
author_facet Juhyun Song
So Yeong Cheon
Won Taek Lee
Kyung Ah Park
Jong Eun Lee
author_sort Juhyun Song
collection DOAJ
description The cyclic AMP-dependent protein kinase (PKA), which activates prosurvival signaling proteins, has been implicated in the expression of long-term potentiation and hippocampal long-term memory. It has come to light that H89 commonly known as the PKA inhibitor have diverse roles in the nervous system that are unrelated to its role as a PKA inhibitor. We have investigated the role of H89 in ischemic and reperfusion injury. First, we examined the expression of postsynaptic density protein 95 (PSD95), microtubule-associated protein 2 (MAP2), and synaptophysin in mouse brain after middle cerebral artery occlusion injury. Next, we examined the role of H89 pretreatment on the expression of brain-derived neurotrophic factor (BDNF), PSD95, MAP2, and the apoptosis regulators Bcl2 and cleaved caspase-3 in cultured neuroblastoma cells exposed to hypoxia and reperfusion injury. In addition, we investigated the alteration of AKT activation in H89 pretreated neuroblastoma cells under hypoxia and reperfusion injury. The data suggest that H89 may contribute to brain recovery after ischemic stroke by regulating neuronal death and proteins related to synaptic plasticity.
format Article
id doaj-art-0e63defa940a428993f82b296ea1a714
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-0e63defa940a428993f82b296ea1a7142025-02-03T05:45:17ZengWileyNeural Plasticity2090-59041687-54432015-01-01201510.1155/2015/374520374520PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic InjuryJuhyun Song0So Yeong Cheon1Won Taek Lee2Kyung Ah Park3Jong Eun Lee4Department of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Anatomy, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaThe cyclic AMP-dependent protein kinase (PKA), which activates prosurvival signaling proteins, has been implicated in the expression of long-term potentiation and hippocampal long-term memory. It has come to light that H89 commonly known as the PKA inhibitor have diverse roles in the nervous system that are unrelated to its role as a PKA inhibitor. We have investigated the role of H89 in ischemic and reperfusion injury. First, we examined the expression of postsynaptic density protein 95 (PSD95), microtubule-associated protein 2 (MAP2), and synaptophysin in mouse brain after middle cerebral artery occlusion injury. Next, we examined the role of H89 pretreatment on the expression of brain-derived neurotrophic factor (BDNF), PSD95, MAP2, and the apoptosis regulators Bcl2 and cleaved caspase-3 in cultured neuroblastoma cells exposed to hypoxia and reperfusion injury. In addition, we investigated the alteration of AKT activation in H89 pretreated neuroblastoma cells under hypoxia and reperfusion injury. The data suggest that H89 may contribute to brain recovery after ischemic stroke by regulating neuronal death and proteins related to synaptic plasticity.http://dx.doi.org/10.1155/2015/374520
spellingShingle Juhyun Song
So Yeong Cheon
Won Taek Lee
Kyung Ah Park
Jong Eun Lee
PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
Neural Plasticity
title PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
title_full PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
title_fullStr PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
title_full_unstemmed PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
title_short PKA Inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulfonamide) Attenuates Synaptic Dysfunction and Neuronal Cell Death following Ischemic Injury
title_sort pka inhibitor h89 n 2 p bromocinnamylamino ethyl 5 isoquinolinesulfonamide attenuates synaptic dysfunction and neuronal cell death following ischemic injury
url http://dx.doi.org/10.1155/2015/374520
work_keys_str_mv AT juhyunsong pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury
AT soyeongcheon pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury
AT wontaeklee pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury
AT kyungahpark pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury
AT jongeunlee pkainhibitorh89n2pbromocinnamylaminoethyl5isoquinolinesulfonamideattenuatessynapticdysfunctionandneuronalcelldeathfollowingischemicinjury